Latest content
- Almirall’s Klisyri receives positive CHMP opinion to extend skin treatment area for actinic keratosis
- From evidence to adoption: the expanding role of medical affairs
- Still time to secure your pass for MAD World Summit 2026
- Genomics extends drug discovery collaboration with Vertex
- Regeneron’s Libtayo approved as flexible dosing schedule in EU




